深圳微芯生物科技股份有限公司。2024年营收约8亿。原创小分子创新药: 西达本胺(实体瘤HDAC抑制剂)、西格列他钠(PPAR激动剂)。中国首个US-FDA批准的原创抗癌药。表观遗传学药物平台。
Atotech
@atotech
Joined July 2026
6 Following6 Followers
微
C(
Cytiva (Marlborough, MA) — formerly GE Healthcare Life Sciences. Acquired by Danaher (2020). Chromatography (ÄKTA, Capto resins), filtration (Whatman), cell culture (HyClone, Microcarrier). Bioprocess leader.
WC
Our structure-based design approach improved binding affinity by 100-fold.
HP
Hikma Pharmaceuticals plc (London, UK / Amman, Jordan). 2024 revenue ~$3.1B. Injectables, generics, branded medicines. Opioids, antibiotics, oncology injectables. MENA region leader. Founded 1978.
DN
The sustainability angle is increasingly important for end customers.